Interplay of integrins and selectins in metastasis.

IF 6.6 2区 医学 Q1 Biochemistry, Genetics and Molecular Biology
Molecular Oncology Pub Date : 2025-06-01 Epub Date: 2025-05-06 DOI:10.1002/1878-0261.70026
Diana Maltseva, Ashot Nersisyan, Alexander Tonevitsky
{"title":"Interplay of integrins and selectins in metastasis.","authors":"Diana Maltseva, Ashot Nersisyan, Alexander Tonevitsky","doi":"10.1002/1878-0261.70026","DOIUrl":null,"url":null,"abstract":"<p><p>Metastasis is a hallmark of malignancy and poses a formidable challenge for oncologists. This complex process begins when the primary malignant cells start to proliferate unlimitedly. Once the tumor reaches a certain size, cancer cells detach from the primary tumor mass and the basal lamina to which they are anchored, eventually invading nearby blood vessels. Within the bloodstream, these tumor cells have to survive and attach to the endothelium at distant sites. Cell-to-cell and cell-to-matrix interactions play an important role during these stages, in which integrins-a family of cell adhesion molecules (CAMs)-stand out as functionally centrally involved. Their expression on the tumor cell surface needs to be dynamically regulated throughout the process of metastasis. During the attachment phase to the endothelium, another group of CAMs, such as E-/P-selectins-primarily expressed on endothelial cells-may also play a critical role in certain malignancies. Additionally, the interplay between integrins and selectins may influence the tumor microenvironment. This review focuses on the role of integrins and their interplay with selectins in metastasis, emphasizing findings from in vivo studies.</p>","PeriodicalId":18764,"journal":{"name":"Molecular Oncology","volume":" ","pages":"1582-1611"},"PeriodicalIF":6.6000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12161467/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/1878-0261.70026","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/5/6 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"Biochemistry, Genetics and Molecular Biology","Score":null,"Total":0}
引用次数: 0

Abstract

Metastasis is a hallmark of malignancy and poses a formidable challenge for oncologists. This complex process begins when the primary malignant cells start to proliferate unlimitedly. Once the tumor reaches a certain size, cancer cells detach from the primary tumor mass and the basal lamina to which they are anchored, eventually invading nearby blood vessels. Within the bloodstream, these tumor cells have to survive and attach to the endothelium at distant sites. Cell-to-cell and cell-to-matrix interactions play an important role during these stages, in which integrins-a family of cell adhesion molecules (CAMs)-stand out as functionally centrally involved. Their expression on the tumor cell surface needs to be dynamically regulated throughout the process of metastasis. During the attachment phase to the endothelium, another group of CAMs, such as E-/P-selectins-primarily expressed on endothelial cells-may also play a critical role in certain malignancies. Additionally, the interplay between integrins and selectins may influence the tumor microenvironment. This review focuses on the role of integrins and their interplay with selectins in metastasis, emphasizing findings from in vivo studies.

整合素和选择素在转移中的相互作用。
转移是恶性肿瘤的标志,对肿瘤学家来说是一个巨大的挑战。当原发恶性细胞开始无限增殖时,这个复杂的过程就开始了。一旦肿瘤达到一定大小,癌细胞就会从原发肿瘤肿块和它们所固定的基底膜上分离出来,最终侵入附近的血管。在血液中,这些肿瘤细胞必须存活并附着在远处的内皮细胞上。细胞与细胞和细胞与基质的相互作用在这些阶段起着重要的作用,其中整合素——细胞粘附分子(CAMs)家族——在功能上起着核心作用。它们在肿瘤细胞表面的表达需要在整个转移过程中受到动态调节。在与内皮细胞的附着阶段,另一组CAMs,如主要在内皮细胞上表达的E-/ p -选择素,也可能在某些恶性肿瘤中发挥关键作用。此外,整合素和选择素之间的相互作用可能影响肿瘤微环境。本文综述了整合素在转移中的作用及其与选择素的相互作用,重点介绍了体内研究的结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Molecular Oncology
Molecular Oncology Biochemistry, Genetics and Molecular Biology-Molecular Medicine
CiteScore
11.80
自引率
1.50%
发文量
203
审稿时长
10 weeks
期刊介绍: Molecular Oncology highlights new discoveries, approaches, and technical developments, in basic, clinical and discovery-driven translational cancer research. It publishes research articles, reviews (by invitation only), and timely science policy articles. The journal is now fully Open Access with all articles published over the past 10 years freely available.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信